Vistin Pharma ASA (DE:VP4) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Saga Pure ASA has increased its stake in Vistin Pharma ASA by purchasing 300,000 shares at a price of NOK 22.50 each, bringing its total ownership to 0.9% of the company. The transaction, associated with board member Øystein Stray Spetalen, occurred on August 23, 2024, and was conducted on the Oslo Stock Exchange.
For further insights into DE:VP4 stock, check out TipRanks’ Stock Analysis page.